DIDO-2
DIDO-2 (COSPAR 2017-008BE) is a nano-satellite of the Israeli / Swiss company SpacePharma.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
DIDO-2 (COSPAR 2017-008BE) is a nano-satellite of the Israeli / Swiss company SpacePharma. The nano-satellite is part of a research project whose goal is to test a miniaturized end-to-end pharmaceutical laboratory (called ) in space under microgravity conditions. The project includes two satellites called DIDO-1 and DIDO-2.
The platforms of the 3U CubeSats are developed and built by the Dutch company ISIS. The first satellite DIDO-1 was originally to fly on a Falcon 9 in 2016. The current (as of 2019) status and plans for this satellite are unknown.
DIDO-2 was successfully launched on February 15, 2017, at 3:58 UTC from Satish Dhawan Space Centre on a PSLV-XL rocket (mission PSLV-C37) that released 104 satellites. The satellite reentered the atmosphere on 12 July 2024. In 2018, a third mission, DIDO-3 was being planned.
Specifications
DIDO-2 is a 3U CubeSat, weighing 4.2 kg.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1355338957 under CC BY-SA 4.0; modifications have been made.